Advancement of Organoid Technology in Regenerative Medicine

Abstract

Purpose Organoids are three-dimensional cultures of stem cells in an environment similar to the body’s extracellular matrix. This is also a novel development in the realm of regenerative medicine. Stem cells can begin to develop into 3D structures by modifying signaling pathways. To form organoids, stem cells are transplanted into the extracellular matrix. Organoids have provided the required technologies to reproduce human tissues. As a result, it might be used in place of animal models in scientific study. The key goals of these investigations are research into viral and genetic illnesses, malignancies, and extracellular vesicles, pharmaceutical discovery, and organ transplantation. Organoids can help pave the road for precision medicine through genetic editing, pharmaceutical development, and cell therapy. Methods PubMed, Google Scholar, and Scopus were used to search for all relevant papers written in English (1907–2021). The study abstracts were scrutinized. Studies on the use of stem-cell-derived organoids in regenerative medicine, organoids as 3D culture models for EVs analysis, and organoids for precision medicine were included. Articles with other irrelevant aims, meetings, letters, commentaries, congress and conference abstracts, and articles with no available full texts were excluded. Results According to the included studies, organoids have various origins, types, and applications in regenerative and precision medicine, as well as an important role in studying extracellular vesicles. Conclusion Organoids are considered a bridge that connects preclinical studies to clinical ones. However, the lack of a standardized protocol and other barriers addressed in this review, hinder the vast use of this technology. Lay Summary Organoids are 3D stem cell propagations in biological or synthetic scaffolds that mimic ECM to allow intercellular or matrix-cellular crosstalk. Because these structures are similar to organs in the body, they can be used as research models. Organoids are medicine’s future hope for organ transplantation, tumor biobank formation, and the development of precision medicine. Organoid models can be used to study cell-to-cell interactions as well as effective factors like inflammation and aging. Bioengineering technologies are also used to define the size, shape, and composition of organoids before transforming them into precise structures. Finally, the importance of organoid applications in regenerative medicine has opened a new window for a better understanding of biological research, as discussed in this study.

Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges

“…The emergence of ISCs and iPSCs represents a promising avenue for future research, and clinical trials will be conducted gradually. 115 , 116 Recently, the research team at Tokyo Medical and Dental University has reported the successful transplantation of the world’s first “organoid” into the intestinal mucosa of a refractory UC patient, marking the beginning of the organoid SC era. The team collected normal intestinal mucosa (including ISCs) from the patient under endoscopy, cultured it in vitro for approximately 1 month, and constructed an “organoid” with a diameter of 0.1–0.2 mm.…”

Human Brain Organoids in Migraine Research: Pathogenesis and Drug Development

“…As organoids carry the genetic information of the source, they hold great potential for biomedical research and preclinical drug testing [ 3 ]. In the future, it is expected that human organoids will become one of the major sources of personalized regenerative medicine, gene repair, and transplantation therapy [ 4 , 5 ]. In theory, human organoids can be created from any organ and used in both basic and clinical research [ 2 ].…”

Current Research Trends in the Application of In Vitro Three-Dimensional Models of Liver Cells

“…An endogenous ECM must be produced to be used as a biomaterial for hepatocytes. Also, 3D structures must be supported, and the key features of stiffness, protein composition, and angiogenesis characteristics must be at least partially reproducible [ 52 ]. Using these biomaterials allows cells to be transplanted directly into the liver without going through the hepatic portal vein, resulting in more cells being transferred to the liver regeneration site.…”